AKT1 and lung adenocarcinoma: Analysis of PIK3CA and STK11 mutations, STK11 protein levels, and AMPK and AKT phosphorylation led to the identification of three major mTOR patterns in lung adenocarcinoma: (1) tumors with minimal or basal mTOR pathway activation, (2) tumors showing higher mTOR activity accompanied by either STK11-inactivating mutation or combined low STK11 expression and low AMPK activation and (3) tumors showing high mTOR activity accompanied by either phosphorylated AKT activation, PIK3CA mutation, or both.